Loss of neuromuscular junction integrity and muscle atrophy in skeletal muscle disuse.


Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
01 2023
Historique:
received: 29 07 2022
revised: 25 11 2022
accepted: 25 11 2022
pubmed: 7 12 2022
medline: 17 12 2022
entrez: 6 12 2022
Statut: ppublish

Résumé

Physical inactivity (PI) is a major risk factor of chronic diseases. A major aspect of PI is loss of muscle mass and strength. The latter phenomenon significantly impacts daily life and represent a major issue for global health. Understandably, skeletal muscle itself has been the major focus of studies aimed at understanding the mechanisms underlying loss of mass and strength. Relatively lesser attention has been given to the contribution of alterations in somatomotor control, despite the fact that these changes can start very early and can occur at multiple levels, from the cortex down to the neuromuscular junction (NMJ). It is well known that exposure to chronic inactivity or immobilization causes a disproportionate loss of force compared to muscle mass, i.e. a loss of specific or intrinsic whole muscle force. The latter phenomenon may be partially explained by the loss of specific force of individual muscle fibres, but several other players are very likely to contribute to such detrimental phenomenon. Irrespective of the length of the disuse period, the loss of force is, in fact, more than two-fold greater than that of muscle size. It is very likely that somatomotor alterations may contribute to this loss in intrinsic muscle force. Here we review evidence that alterations of one component of somatomotor control, namely the neuromuscular junction, occur in disuse. We also discuss some of the novel players in NMJ stability (e.g., homer, bassoon, pannexin) and the importance of new established and emerging molecular markers of neurodegenerative processes in humans such as agrin, neural-cell adhesion molecule and light-chain neurofilaments.

Identifiants

pubmed: 36471545
pii: S1568-1637(22)00252-5
doi: 10.1016/j.arr.2022.101810
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101810

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Giuseppe Sirago (G)

Department of Biomedical Sciences, University of Padova, Padova 35131, Italy. Electronic address: giuseppe.sirago@unipd.it.

Maria A Pellegrino (MA)

Department of Molecular Medicine, University of Pavia, Pavia 27100, Italy.

Roberto Bottinelli (R)

Department of Molecular Medicine, University of Pavia, Pavia 27100, Italy; IRCCS Mondino Foundation, Pavia 27100, Italy.

Martino V Franchi (MV)

Department of Biomedical Sciences, University of Padova, Padova 35131, Italy.

Marco V Narici (MV)

Department of Biomedical Sciences, University of Padova, Padova 35131, Italy; CIR-MYO Myology Center, University of Padova, Padova 35131, Italy. Electronic address: marco.narici@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH